Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1352706

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1352706

Global Liquid Biopsy Market 2023-2027

PUBLISHED:
PAGES: 158 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

The liquid biopsy market is forecasted to grow by USD 2,168.39 mn during 2022-2027, accelerating at a CAGR of 19.54% during the forecast period. The report on the liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of cancer, the growing focus on personalized medicine for cancer care, and advancements in liquid biopsy technologies.

Technavio's liquid biopsy market is segmented as below:

Market Scope
Base Year2022
End Year2027
Series Year2023-2027
Growth MomentumAccelerate
YOY 202318.31%
CAGR19.54%
Incremental Value$2,168.39mn

By Application

  • Cancer applications
  • Non-cancer applications

By Technology

  • CTC and ctDNA
  • Exosome and RNA

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing funding/investment for liquid biopsy as one of the prime reasons driving the liquid biopsy market growth during the next few years. Also, strategic partnerships among academic institutions, industries and M&A and emerging applications of liquid biopsy will lead to sizable demand in the market.

The report on the liquid biopsy market covers the following areas:

  • Liquid biopsy market sizing
  • Liquid biopsy market forecast
  • Liquid biopsy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liquid biopsy market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, ANGLE Plc, Bio Rad Laboratories Inc., Bio Techne Corp., Biocept Inc., Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corp., F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Inivata Ltd., MDXHEALTH SA, Mesa Laboratories Inc., Myriad Genetics Inc., Novogene Co. Ltd., OncoCyte Corp., QIAGEN NV, and SAGA Diagnostics AB. Also, the liquid biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR45000

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global liquid biopsy market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global liquid biopsy market 2017 - 2021 ($ million)
  • 4.2 Application Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
  • 4.3 Technology Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

  • 6.1 Market segments
  • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
  • 6.2 Comparison by Application
  • Exhibit 32: Chart on Comparison by Application
  • Exhibit 33: Data Table on Comparison by Application
  • 6.3 Cancer applications - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Cancer applications - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Cancer applications - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Cancer applications - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Cancer applications - Year-over-year growth 2022-2027 (%)
  • 6.4 Non-cancer applications - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Non-cancer applications - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Non-cancer applications - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Non-cancer applications - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Non-cancer applications - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Application
  • Exhibit 42: Market opportunity by Application ($ million)
  • Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Technology

  • 7.1 Market segments
  • Exhibit 44: Chart on Technology - Market share 2022-2027 (%)
  • Exhibit 45: Data Table on Technology - Market share 2022-2027 (%)
  • 7.2 Comparison by Technology
  • Exhibit 46: Chart on Comparison by Technology
  • Exhibit 47: Data Table on Comparison by Technology
  • 7.3 CTC and ctDNA - Market size and forecast 2022-2027
  • Exhibit 48: Chart on CTC and ctDNA - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Data Table on CTC and ctDNA - Market size and forecast 2022-2027 ($ million)
  • Exhibit 50: Chart on CTC and ctDNA - Year-over-year growth 2022-2027 (%)
  • Exhibit 51: Data Table on CTC and ctDNA - Year-over-year growth 2022-2027 (%)
  • 7.4 Exosome and RNA - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Exosome and RNA - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Exosome and RNA - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Exosome and RNA - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Exosome and RNA - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Technology
  • Exhibit 56: Market opportunity by Technology ($ million)
  • Exhibit 57: Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 61: Chart on Geographic comparison
  • Exhibit 62: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Canada - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.9 Germany - Market size and forecast 2022-2027
  • Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.10 UK - Market size and forecast 2022-2027
  • Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 99: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 104: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 105: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
  • 12.3 A. Menarini Industrie Farmaceutiche Riunite Srl
  • Exhibit 107: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
  • Exhibit 108: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
  • Exhibit 109: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
  • 12.4 ANGLE Plc
  • Exhibit 110: ANGLE Plc - Overview
  • Exhibit 111: ANGLE Plc - Product / Service
  • Exhibit 112: ANGLE Plc - Key offerings
  • 12.5 Bio Techne Corp.
  • Exhibit 113: Bio Techne Corp. - Overview
  • Exhibit 114: Bio Techne Corp. - Business segments
  • Exhibit 115: Bio Techne Corp. - Key news
  • Exhibit 116: Bio Techne Corp. - Key offerings
  • Exhibit 117: Bio Techne Corp. - Segment focus
  • 12.6 Biocept Inc.
  • Exhibit 118: Biocept Inc. - Overview
  • Exhibit 119: Biocept Inc. - Product / Service
  • Exhibit 120: Biocept Inc. - Key offerings
  • 12.7 Biodesix Inc.
  • Exhibit 121: Biodesix Inc. - Overview
  • Exhibit 122: Biodesix Inc. - Product / Service
  • Exhibit 123: Biodesix Inc. - Key offerings
  • 12.8 CellMax Inc.
  • Exhibit 124: CellMax Inc. - Overview
  • Exhibit 125: CellMax Inc. - Product / Service
  • Exhibit 126: CellMax Inc. - Key offerings
  • 12.9 CIRCULOGENE
  • Exhibit 127: CIRCULOGENE - Overview
  • Exhibit 128: CIRCULOGENE - Product / Service
  • Exhibit 129: CIRCULOGENE - Key offerings
  • 12.10 Exact Sciences Corp.
  • Exhibit 130: Exact Sciences Corp. - Overview
  • Exhibit 131: Exact Sciences Corp. - Product / Service
  • Exhibit 132: Exact Sciences Corp. - Key offerings
  • 12.11 F. Hoffmann La Roche Ltd.
  • Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.12 Guardant Health Inc.
  • Exhibit 138: Guardant Health Inc. - Overview
  • Exhibit 139: Guardant Health Inc. - Product / Service
  • Exhibit 140: Guardant Health Inc. - Key news
  • Exhibit 141: Guardant Health Inc. - Key offerings
  • 12.13 Illumina Inc.
  • Exhibit 142: Illumina Inc. - Overview
  • Exhibit 143: Illumina Inc. - Business segments
  • Exhibit 144: Illumina Inc. - Key news
  • Exhibit 145: Illumina Inc. - Key offerings
  • Exhibit 146: Illumina Inc. - Segment focus
  • 12.14 MDXHEALTH SA
  • Exhibit 147: MDXHEALTH SA - Overview
  • Exhibit 148: MDXHEALTH SA - Product / Service
  • Exhibit 149: MDXHEALTH SA - Key offerings
  • 12.15 Myriad Genetics Inc.
  • Exhibit 150: Myriad Genetics Inc. - Overview
  • Exhibit 151: Myriad Genetics Inc. - Product / Service
  • Exhibit 152: Myriad Genetics Inc. - Key offerings
  • 12.16 QIAGEN NV
  • Exhibit 153: QIAGEN NV - Overview
  • Exhibit 154: QIAGEN NV - Product / Service
  • Exhibit 155: QIAGEN NV - Key news
  • Exhibit 156: QIAGEN NV - Key offerings
  • 12.17 SAGA Diagnostics AB
  • Exhibit 157: SAGA Diagnostics AB - Overview
  • Exhibit 158: SAGA Diagnostics AB - Product / Service
  • Exhibit 159: SAGA Diagnostics AB - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 160: Inclusions checklist
  • Exhibit 161: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 162: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 163: Research methodology
  • Exhibit 164: Validation techniques employed for market sizing
  • Exhibit 165: Information sources
  • 13.5 List of abbreviations
  • Exhibit 166: List of abbreviations
Product Code: IRTNTR45000

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global liquid biopsy market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Application - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Application - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Application
  • Exhibits33: Data Table on Comparison by Application
  • Exhibits34: Chart on Cancer applications - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Cancer applications - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Cancer applications - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Cancer applications - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Non-cancer applications - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Non-cancer applications - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Non-cancer applications - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Non-cancer applications - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Application ($ million)
  • Exhibits43: Data Table on Market opportunity by Application ($ million)
  • Exhibits44: Chart on Technology - Market share 2022-2027 (%)
  • Exhibits45: Data Table on Technology - Market share 2022-2027 (%)
  • Exhibits46: Chart on Comparison by Technology
  • Exhibits47: Data Table on Comparison by Technology
  • Exhibits48: Chart on CTC and ctDNA - Market size and forecast 2022-2027 ($ million)
  • Exhibits49: Data Table on CTC and ctDNA - Market size and forecast 2022-2027 ($ million)
  • Exhibits50: Chart on CTC and ctDNA - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Data Table on CTC and ctDNA - Year-over-year growth 2022-2027 (%)
  • Exhibits52: Chart on Exosome and RNA - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Data Table on Exosome and RNA - Market size and forecast 2022-2027 ($ million)
  • Exhibits54: Chart on Exosome and RNA - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Data Table on Exosome and RNA - Year-over-year growth 2022-2027 (%)
  • Exhibits56: Market opportunity by Technology ($ million)
  • Exhibits57: Data Table on Market opportunity by Technology ($ million)
  • Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits61: Chart on Geographic comparison
  • Exhibits62: Data Table on Geographic comparison
  • Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Market opportunity By Geographical Landscape ($ million)
  • Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits101: Impact of drivers and challenges in 2022 and 2027
  • Exhibits102: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits103: Overview on factors of disruption
  • Exhibits104: Impact of key risks on business
  • Exhibits105: Vendors covered
  • Exhibits106: Matrix on vendor position and classification
  • Exhibits107: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
  • Exhibits108: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
  • Exhibits109: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
  • Exhibits110: ANGLE Plc - Overview
  • Exhibits111: ANGLE Plc - Product / Service
  • Exhibits112: ANGLE Plc - Key offerings
  • Exhibits113: Bio Techne Corp. - Overview
  • Exhibits114: Bio Techne Corp. - Business segments
  • Exhibits115: Bio Techne Corp. - Key news
  • Exhibits116: Bio Techne Corp. - Key offerings
  • Exhibits117: Bio Techne Corp. - Segment focus
  • Exhibits118: Biocept Inc. - Overview
  • Exhibits119: Biocept Inc. - Product / Service
  • Exhibits120: Biocept Inc. - Key offerings
  • Exhibits121: Biodesix Inc. - Overview
  • Exhibits122: Biodesix Inc. - Product / Service
  • Exhibits123: Biodesix Inc. - Key offerings
  • Exhibits124: CellMax Inc. - Overview
  • Exhibits125: CellMax Inc. - Product / Service
  • Exhibits126: CellMax Inc. - Key offerings
  • Exhibits127: CIRCULOGENE - Overview
  • Exhibits128: CIRCULOGENE - Product / Service
  • Exhibits129: CIRCULOGENE - Key offerings
  • Exhibits130: Exact Sciences Corp. - Overview
  • Exhibits131: Exact Sciences Corp. - Product / Service
  • Exhibits132: Exact Sciences Corp. - Key offerings
  • Exhibits133: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits134: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits135: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits138: Guardant Health Inc. - Overview
  • Exhibits139: Guardant Health Inc. - Product / Service
  • Exhibits140: Guardant Health Inc. - Key news
  • Exhibits141: Guardant Health Inc. - Key offerings
  • Exhibits142: Illumina Inc. - Overview
  • Exhibits143: Illumina Inc. - Business segments
  • Exhibits144: Illumina Inc. - Key news
  • Exhibits145: Illumina Inc. - Key offerings
  • Exhibits146: Illumina Inc. - Segment focus
  • Exhibits147: MDXHEALTH SA - Overview
  • Exhibits148: MDXHEALTH SA - Product / Service
  • Exhibits149: MDXHEALTH SA - Key offerings
  • Exhibits150: Myriad Genetics Inc. - Overview
  • Exhibits151: Myriad Genetics Inc. - Product / Service
  • Exhibits152: Myriad Genetics Inc. - Key offerings
  • Exhibits153: QIAGEN NV - Overview
  • Exhibits154: QIAGEN NV - Product / Service
  • Exhibits155: QIAGEN NV - Key news
  • Exhibits156: QIAGEN NV - Key offerings
  • Exhibits157: SAGA Diagnostics AB - Overview
  • Exhibits158: SAGA Diagnostics AB - Product / Service
  • Exhibits159: SAGA Diagnostics AB - Key offerings
  • Exhibits160: Inclusions checklist
  • Exhibits161: Exclusions checklist
  • Exhibits162: Currency conversion rates for US$
  • Exhibits163: Research methodology
  • Exhibits164: Validation techniques employed for market sizing
  • Exhibits165: Information sources
  • Exhibits166: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!